Low-Volume Rally Drives Outlook Therapeutics 127% Higher Ahead of FDA Verdict
Outlook Therapeutics shares have more than doubled – and then some – over the past month, but the price action...
Outlook Therapeutics shares have more than doubled – and then some – over the past month, but the price action...
The narrative for Applied Materials has turned decidedly mixed. The chip-equipment giant is expanding into a new South Korean hub...
The cybersecurity giant CrowdStrike is delivering explosive AI-driven growth, yet the stock is locked in a tug-of-war between Wall Street’s...
Germany’s workplace health landscape is shifting, driven by stark new figures on staff retention. Data from the German Trade Union...
Broadcom's AI-fueled rally is running into a pair of obstacles that are giving investors pause. The chipmaker’s stock slipped nearly...
Nvidia’s stock has been bouncing between two very different narratives this week — one rooted in physical infrastructure limits, the...
Volkswagen's preferred shares have clawed back more than 9% from their July low, yet the stock still trades at roughly...
Income-hungry investors are rotating heavily into dividend-paying equities, with the VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF absorbing €414...
A Lancashire-based container manufacturer has been ordered to pay more than £36,000 in fines and costs after exposing workers to...
Diginex is juggling two high-stakes narratives this week: a fresh push to expand its commercial footprint and a countdown to...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com